Powering next generation targeted immunotherapies, come and meet with our CTO, Shay Tayeb, and learn more about NADAV – our novel oncolytic virus platform technology.
news
ViruCure to attend the Armed Oncolytic Immunotherapies Summit Europe 2018, 26-28 June, Frankfurt, Germany
Meet with our CTO, Shay Tayeb, at the leading end-to-end meeting focused on the next generation of oncolytic virus therapies and discover more about ViruCure’s oncolytic virus technology, NADAV.
ViruCure to attend the Biotechnology Innovation Organization, 4-7 June, Boston, USA
Come and meet with our CEO & Co-founder, Yoram Drucker at BIO 2018 to learn more about ViruCure’s breakthrough NADAV technology to fight cancer.